Showing results (101-110 of 179) with videos related to

Sort By:
Pageof 18
The American Journal of Pathology|March 27, 2024
A Deep Learning-Based Assessment Pipeline for Intraepithelial and Stromal Tumor-Infiltrating Lymphocytes in High-Grade Serous Ovarian CarcinomaKohei Hamada, Ryusuke Murakami, Akihiko Ueda, et al.
Molecular and Clinical Oncology|April 29, 2016
Magnetic resonance imaging findings and prognosis of gastric-type mucinous adenocarcinoma (minimal deviation adenocarcinoma or adenoma malignum) of the uterine corpus: Two case reportsMayo Hino, Ken Yamaguchi, Kaoru Abiko, et al.
Magnetic Resonance Imaging|October 23, 2021
Radiomic machine learning for pretreatment assessment of prognostic risk factors for endometrial cancer and its effects on radiologists' decisions of deep myometrial invasionSatoshi Otani, Yuki Himoto, Mizuho Nishio, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|August 4, 2025
Origin of Endometrioid Carcinoma Adjacent to Extraovarian Endometriosis: Detailed Molecular AnalysesTomo Yamagata, Koichi Watanabe, Koji Yamanoi, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|September 10, 2024
Origin of Peritoneal Cancer With Features of High-grade Serous Carcinoma: A Detailed Molecular AnalysisTomo Yamagata, Koichi Watanabe, Koji Yamanoi, et al.
International Journal of Clinical Oncology|November 16, 2024
Electronic patient-reported outcomes as digital therapeutics for patients with cancer: a narrative review of current practices and future directionsKen Yamaguchi, Nozomi Higashiyama, Maki Umemiya, et al.
Cancer Research|November 18, 2015
Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian CancerJin Peng, Junzo Hamanishi, Noriomi Matsumura, et al.
Cancer Immunology, Immunotherapy : CII|January 27, 2026
Oligoclonal B cell expansion and passenger fusion genes predict response to Nivolumab in recurrent ovarian cancer: phase II Kyoto trialRyusuke Murakami, Junzo Hamanishi, J B Brown, et al.
Scientific Reports|October 4, 2019
Acquisition of a side population fraction augments malignant phenotype in ovarian cancerKoji Yamanoi, Tsukasa Baba, Kaoru Abiko, et al.
Scientific Reports|June 2, 2021
Combination of gene set signatures correlates with response to nivolumab in platinum-resistant ovarian cancerRyusuke Murakami, Junzo Hamanishi, J B Brown, et al.
Pageof 18